Hyperthermia enhances the efficacy of PD-1 inhibitor plus chemotherapy in PD-L1 CPS-negative advanced gastric cancer - Top-Institutions - MDSpire

Hyperthermia enhances the efficacy of PD-1 inhibitor plus chemotherapy in PD-L1 CPS-negative advanced gastric cancer

  • By

  • Weihang Li

  • Xin Sun

  • Ping Li

  • Ting Wang

  • Panling Xu

  • May 13, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    First Affiliated Hospital of Anhui Medical University
    First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    National Cancer Center Hospital East
    National Cancer Center Hospital East

    Kashiwa, Chiba

    Key Differentiators

    • Oncology

  • #4

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, Île-de-France

    Key Differentiators

    • Oncology

  • #5

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

Original Source(s)

Hyperthermia enhances the efficacy of PD-1 inhibitor plus chemotherapy in PD-L1 CPS-negative advanced gastric cancer

  • by Weihang Li, Xin Sun, Ping Li, Ting Wang, Panling Xu

  • May 13, 2026

Related Content

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate

Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential